Peer Reviewed Publications and Abstracts
Study results have been presented at major medical conferences and published in distinguished medical journals.
“Clinical data from several studies on miraDry involving more than
200 patients demonstrated compelling efficacy, duration and patient safety.”
Dr. Michael Kaminer, Chestnut Hill, MA – Dermatologist & Cosmetic Surgeon
Long-term Efficacy and Quality of Life Assessment for Treatment of Axillary Hyperhidrosis With a Microwave Device
Mark Lupin, MD et al; Dermatol Surg 2014; 40: 805-807
This letter to the editor reports 2-year follow-up results showing stable efficacy and patient satisfaction.
Two years after treatment, subjects reported:
- >90% efficacy
- DLQI reduction of >10 points
- Odor not a problem (89% of subjects vs 16% at baseline)
Jeremy Brauer, MD, Roy Geronemus, MD, et al; 2013 ASLMS Annual Meeting (April 2013)Learn More »
A Retrospective Analysis of the Treatment of Axillary Hyperhidrosis with a Novel Microwave Technology
Cameron Rokhsar, MD and Min Jeong Kim, MD; 2013 ASLMS Annual Meeting (April 2013), AbstractLearn More »
Carolyn Jacob, MD; Semin Cutan Med Surg 2013; 32:2-8
Review article of available treatments, including comprehensive overview of miraDry® technology and integration of procedure in everyday practice.
Mark Lupin, MD and Chih-ho Hong, MD; 2012 ASDS Annual Meeting (October 2012),Learn More »
Mark Lupin, MD et al; 2012 ASLMS Annual Meeting (April 2012)
Mark Lupin, MD et al; J Am Acad Dermatol 2012; 66; AB215,
H. Chih-Ho Hong, MD, Mark Lupin, MD et al; Dermatologic Surgery 2012; 38:728-735
Multicenter study evaluating commercial miraDry device;
1-year data showing:
- >90% efficacy
- 90% patient satisfaction
- 82% reduction of sweat (gravimetric)
A Randomized, Blinded Clinical Evaluation of a Novel Microwave Device for Treating Axillary Hyperhidrosis: The Dermatologic Reduction in Underarm Perspiration Study
Dee Anna Glaser, MD et al; Dermatologic Surgery 2012; 38:185-191
Pivotal, double-blind, sham-controlled multicenter study evaluating investigational generation-2 miraDry system. Study was used for FDA clearance.